Cover Image
市場調查報告書

視覺障礙:全球臨床實驗趨勢

Vision Disorders Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339398
出版日期 內容資訊 英文 99 Pages
訂單完成後即時交付
價格
Back to Top
視覺障礙:全球臨床實驗趨勢 Vision Disorders Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月31日 內容資訊: 英文 99 Pages
簡介

本報告提供視覺障礙臨床實驗相關之最新趨勢分析,提供您各地區主要國家的臨床實驗數量,彙整臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 視覺障礙
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上視覺障礙的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上視覺障礙的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

視覺障礙治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • ThromboGenics NV
    • Celerion, Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • Allegro Ophthalmics, LLC
    • Beyond Blue Limited
    • Bayer AG
    • Asociacion para Evitar la Ceguera en Mexico I.A.P.
    • Alcon, Inc.
    • Alberta Innovates- Health Solutions
  • 有代表性的研究機關·醫院臨床實驗概要
    • U.S. Department of Veterans Affairs
    • National Eye Institute
    • Postgraduate Institute of Medical Education and Research
    • Case Western Reserve University
    • Charite - Universitatsmedizin Berlin
    • Dong Rae Bong Seng Hospital
    • Jaeb Center for Health Research
    • L.V. Prasad Eye Institute
    • Moorfields Eye Hospital NHS Foundation Trust
    • Neurological Institute of Colombia

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2802CTIDB

GlobalData's clinical trial report, "Vision Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Vision Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Vision Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Vision Disorders
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Vision Disorders to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Vision Disorders to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Vision Disorders
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Vision Disorders Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Vision Disorders
      • Jun 29, 2015: NightstaRx and The University of Alberta announce the start of the first Canadian Gene Therapy Study to Treat Choroideremia
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • ThromboGenics NV
      • Clinical Trial Overview of ThromboGenics NV
      • Celerion, Inc.
      • Clinical Trial Overview of Celerion, Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Allegro Ophthalmics, LLC
      • Clinical Trial Overview of Allegro Ophthalmics, LLC
      • Beyond Blue Limited
      • Clinical Trial Overview of Beyond Blue Limited
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Asociacion para Evitar la Ceguera en Mexico I.A.P.
      • Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P.
      • Alcon, Inc.
      • Clinical Trial Overview of Alcon, Inc.
      • Alberta Innovates- Health Solutions
      • Clinical Trial Overview of Alberta Innovates- Health Solutions
    • Clinical Trial Overview of Top Institutes / Government
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Postgraduate Institute of Medical Education and Research
      • Clinical Trial Overview of Postgraduate Institute of Medical Education and Research
      • Case Western Reserve University
      • Clinical Trial Overview of Case Western Reserve University
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Dong Rae Bong Seng Hospital
      • Clinical Trial Overview of Dong Rae Bong Seng Hospital
      • Jaeb Center for Health Research
      • Clinical Trial Overview of Jaeb Center for Health Research
      • L.V. Prasad Eye Institute
      • Clinical Trial Overview of L.V. Prasad Eye Institute
      • Moorfields Eye Hospital NHS Foundation Trust
      • Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust
      • Neurological Institute of Colombia
      • Clinical Trial Overview of Neurological Institute of Colombia
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Vision Disorders Therapeutics, Global, Clinical Trials by Region, 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Vision Disorders Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Vision Disorders to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Vision Disorders to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Vision Disorders Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Vision Disorders Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Vision Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Celerion, Inc., 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Allegro Ophthalmics, LLC, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Beyond Blue Limited, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Innovates- Health Solutions, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Rae Bong Seng Hospital , 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Jaeb Center for Health Research, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by L.V. Prasad Eye Institute, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015*
  • Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurological Institute of Colombia, 2015*

List of Figures

  • Vision Disorders Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Vision Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Vision Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Vision Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Vision Disorders to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Vision Disorders to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Vision Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Vision Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Vision Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top